The European Medicines Agency (EMA) announced it will review new safety data on the Alzheimer’s disease drug Leqembi (lecanemab). This follows a prior decision to recommend its use in the ...

AMSTERDAM – The European Medicines Agency (EMA) said on Jan 27 that it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...

EMA Partners India IPO worth ₹76 crore is a combination of a fresh share sale of 53.34 lakh shares worth ₹66.14 crore and an offer for sale (OFS) of 7.96 lakh shares, totalling ₹9.87 crore ...

EMA Partners IPO allotment date today: EMA Partners India IPO allotment share allotment will be finalised today (Wednesday, January 22). The investors who applied for the issue can check the EMA ...

Biogen BIIB announced that the FDA and EMA have accepted its regulatory filings seeking label expansion for a higher dose of its blockbuster spinal muscular atrophy (SMA) drug Spinraza.

Whether you've been prescribed Mounjaro (tirzepatide) for type 2 diabetes, weight loss, or both, you're likely wondering what to eat (and not to eat) while taking the medication. After all ...